NEXENTIS TECHNOLOGIES INC. Repayments of Short-term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Repayments of Short-term Debt of $38.97 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2023-03-27
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for the quarter ending 2021-12-31 was $18.70K, a 36.51% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for the quarter ending 2021-09-30 was $13.87K, a 40.97% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for the quarter ending 2021-06-30 was $3.23K, a 53.65% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for the quarter ending 2021-03-31 was $3.18K, a 69.64% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for fiscal 2021 was $38.97K, a 4.87% decline from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for fiscal 2020 was $40.97K.
- NEXENTIS TECHNOLOGIES INC. repayments of short-term debt for fiscal 2018 was $8.37K.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $18.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $32.56K derived: sum of 2 quarters · filed 2023-03-27 | $35.79K derived: sum of 3 quarters · filed 2023-03-27 | $38.97K 10-K · filed 2023-03-27 |
| 2021-09-30 | $13.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $17.09K derived: sum of 2 quarters · filed 2021-11-15 | $20.27K 10-Q · filed 2021-11-15 | $33.97K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $3.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $6.41K 10-Q · filed 2021-08-16 | $20.10K derived: sum of 3 quarters · filed 2022-03-31 | $29.94K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $3.18K 10-Q · filed 2021-05-18 | $16.88K derived: sum of 2 quarters · filed 2022-03-31 | $26.71K derived: sum of 3 quarters · filed 2022-03-31 | $33.67K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | $13.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $23.53K derived: sum of 2 quarters · filed 2022-03-31 | $30.50K derived: sum of 3 quarters · filed 2022-03-31 | $40.97K 10-K · filed 2022-03-31 |
| 2020-09-30 | $9.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $16.80K derived: sum of 2 quarters · filed 2021-11-15 | $27.27K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $6.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $17.43K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $10.47K 10-Q · filed 2021-05-18 | |||
| 2018-12-31 | $8.37K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |